IPBronch.com | Interventional Pulmonology

Thorax Jun 15, 2026

Multimodality curative-intent treatment in NSCLC: an unprecedented era of change 2017-2025.

Study Takeaway

IPs must stay updated on these systemic therapy shifts as they influence the timing and necessity of diagnostic and staging bronchoscopy in the multimodality care pathway.

Evison M; Ahmed T; Chitnis M; Ward R; Netto D; Cove-Smith L

IP Score: 6/10 View Analysis →

Chest May 29, 2026

Smoking-Related Comorbidities Detected Through Low-dose CT Lung Cancer Screening: Current Evidence and Future Directions.

Study Takeaway

Highlights the importance of multidisciplinary management for incidental findings detected during lung cancer screening, which often leads to IP referral for diagnostic biopsy.

Revel MP; Goo JM; Vliegenthart R; Silva M; Snoeckx A

IP Score: 7/10 View Analysis →

Chest May 18, 2026

Natural history, treatment, survival, and causes of mortality in patients with subsolid and ground-glass nodules.

Study Takeaway

Provides critical context for the decision-making process regarding when to pursue diagnostic bronchoscopy versus radiographic surveillance for indeterminate nodules.

Bader JM; Prince SR; de Santis W; Kane ER; Tanoue L; Bader AS

IP Score: 7/10 View Analysis →

American journal of respiratory and critical care medicine May 4, 2026

Toward Precision in Lung Cancer: Screening, Susceptibility, and Therapeutic Resistance.

Study Takeaway

Highlights the evolving landscape of lung cancer management, which informs the diagnostic and staging roles of interventional pulmonologists in the era of precision oncology.

Nana-Sinkam P

IP Score: 6/10 View Analysis →

Journal of thoracic oncology May 2, 2026

Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung Cancer.

Study Takeaway

Relevant for IP clinicians involved in the diagnostic workup and tissue acquisition for molecular profiling in lung cancer patients.

Del Rio B; Masini S; Cáceres-Galvis C; Torres-Jiménez J; Bote H; Zurera M

IP Score: 6/10 View Analysis →

Journal of thoracic oncology Apr 27, 2026

Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma.

Study Takeaway

Relevant for IP clinicians performing diagnostic biopsies and staging, as these histologic features are often identified on tissue samples obtained via bronchoscopy.

Abolfathi H; Maranda-Robitaille M; Lamaze FC; Kordahi M; Armero VS; Orain M

IP Score: 6/10 View Analysis →

Respirology Mar 25, 2026

The Implications of 9th Lung Cancer TNM Classification on Interventional Pulmonology

Study Takeaway

Essential reading for IP clinicians to understand changes in staging criteria that dictate biopsy and nodal sampling strategies.

Authors not listed

IP Score: 9/10 View Analysis →

Respiration Mar 23, 2026

Feasibility and Safety of a Robotic-Assisted Optical Navigation System for Pulmonary Nodule Percutaneous Cryoablation: A Prospective, Single-Center, Single-Arm Pilot Study

Study Takeaway

Highlights the expanding role of robotic platforms in image-guided percutaneous thoracic interventions.

Authors not listed

IP Score: 9/10 View Analysis →

JBIP Mar 18, 2026

Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Detection of PET-CT Negative Contralateral Hilar Lymph Node Metastasis in the Staging of Non-small cell Lung Cancer

Study Takeaway

Reinforces the importance of thorough EBUS-TBNA staging, even in PET-negative contralateral nodes, to prevent surgical staging errors.

Tharwani, Arsal; Shaller, Brian; Aravena, Carlos; Rathunde, Lucas; Sarda, Yash; Cicenia, Joseph; Sethi, Sonali; Ribeiro Neto, Manuel L.; Choi, Humberto; Gillespie, Colin; Gildea, Thomas; Lam, Louis; Mehta, Atul; Machuzak, Michael; Mazzone, Peter; Wang, Yifan; Almeida, Francisco A.

IP Score: 9/10 View Analysis →

Respirology Mar 18, 2026